BLOGSCAN - Pfizer Trumpets Good News About Lipitor, Whispers Bad News

On both Pharmalot and the Wall Street Journal Health Blog are posts about how Pfizer Inc., the world's largest drug company, trumpeted the 14% superiority of its cholesterol lowering drug Lipitor (atorvastatin) over generic simvastatin based on an observational study, then recently very quietly filed a statement with the US Securities and Exchange Commission (SEC) of all places noting that the original findings were incorrect, and that Lipitor did not show a statistically significant advantage over simvastatin.

Related Post:

Widget by [ Iptek-4u ]